Leiomyosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
Condition:   Leiomyosarcoma Intervention:   Drug: Dinutuximab Beta, Zoledronic acid, Interleukin-2 Sponsors:   Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest;   EUSA Pharma, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2021 Category: Research Source Type: clinical trials

A Trial of TTI-621 in Combination With Doxorubicin in Patients With Leiomyosarcoma
Condition:   Leiomyosarcoma Interventions:   Drug: TTI-621;   Drug: Doxorubicin Sponsor:   Trillium Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2021 Category: Research Source Type: clinical trials